Anita Deswal

Department Chair

The University of Texas MD Anderson Cancer Center
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (24)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Aims Radiation therapy (RT) is an integral component of cancer therapy but associated with adverse events. Our goal was to establish risk prediction models for major adverse cardiovascular and cerebrovascular events (MACCE) after chest RT. Methods and results A retrospective study of lung/breast cancer patients who had chest RT with planning CT at Mayo Clinic between 01/2010 and 01/2014. Predictive models were developed based on weighted independent predictors using a derivation (406 lung and 711 breast cancer) and validation cohort (179 lung and 234 breast cancer). Patient characteristics, pre-RT CT for coronary artery calcification (CAC), and post-RT MACCE data were reviewed. Post-RT MACCE occurred in 6.1 and 5.6% in the derivation and validation cohort over a mean follow-up of 42 ± 13 months. Post-therapy model (C2AD2) included CAC (two points), MACCE history (two points), age ≥74 (three points), DM (two points), and mean heart radiation dose ≥ 850 mGy (two points), and pre-therapy model (C2AD) included post-therapy model parameters minus mean heart radiation dose. Both models stratified patients into three risk groups: low (0–2), intermediate (3–5), and high (≥6). Post-RT MACCE across these groups were 2.7, 8.9, and 19.8% in the derivation, and 3.9, 6.6, and 16.4% in the validation cohort for post-therapy model (C2AD2) and 2.8, 9.2, and 20.4% in the derivation and 3.7, 9.2, and 13.2% in the validation cohort for pre-therapy model. Both models showed statistically significant graded survival outcome. Conclusion Post-therapy (C2AD2) and pre-therapy (C2AD) models are simple, easy to use and effective tools to stratify breast and lung cancer patients undergoing chest radiation for post-RT MACCE.

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Collaborators (35)

Amit Pursnani

-

UNITED STATES
View details

Paul S. Brookes

Professor

University of Rochester

UNITED STATES
View details

Raul Cordoba

Hospital Universitario Fundación Jiménez Díaz

SPAIN
View details

Cezar Iliescu

Professor of Medicine, Interventional Cardiology

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Wei-Ting Chang

Associate Prof

National Sun Yat-Sen University

TAIWAN
View details

Keri Schadler

Associate Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Meenakshi Bhattacharjee

Professor & Director of Neuropathology

The University of Texas Health Science Center at Houston

UNITED STATES
View details

Han Zhu

Stanford University School of Medicine

UNITED STATES
View details

Avirup Guha

Director of Cardio-Oncology

Augusta University

UNITED STATES
View details

Iqbal Mahmud

Assistant Professor

Lamar University

UNITED STATES
View details

Efstratios Koutroumpakis

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Louis Maximilian Buja

Professor

The University of Texas Health Science Center at Houston

UNITED STATES
View details

Nordin M.J. Hanssen

Amsterdam University Medical Centers

NETHERLANDS
View details

Lorenz Lehmann

Head of Cardio-Oncology Unit

University Hospital Heidelberg

GERMANY
View details

Saadia Faiz

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

John Cooke

Professor and Department Chair

Houston Methodist Research Institute

UNITED STATES
View details

Guangyu Wang

Assistant Professor

Houston Methodist

UNITED STATES
View details

James P. Allison

Professor and Chair

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Yibo Dai

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Arjun K Ghosh

University College London Hospitals NHS Foundation Trust

UNITED KINGDOM
View details

Ying H. Shen

Baylor College of Medicine

UNITED STATES
View details

Wendong Yu

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Jun-ichi Abe

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Teresa López-Fernández

La Paz University Hospital

SPAIN
View details

Sreyashi Basu

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Nicolas Palaskas

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Sumit Subudhi

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

sivareddy kotla

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Jinzhong Yang

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

James F. Martin

Professor

Baylor College of Medicine

UNITED STATES
View details

Kirk Roberts

Associate Professor

The University of Texas Health Science Center at Houston

UNITED STATES
View details

Linghua Wang

Executive Director & Head

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Jared Burks

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Sandeep Sahay

Associate Professor

Texas A&M University

UNITED STATES
View details

Erin Seeley

Mass Spectrometry Imaging Facility Director

University of Texas at Austin

UNITED STATES
View details